Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
ROIV	ROIVANT SCIENCES LTD	$25.45B	-6.90%	-5.70%	-3.07%	-4.30%	0.09	18.37	84.40%	-3,629.20%	-2,015.04%
NUVB	NUVATION BIO INC	$1.96B	-44.10%	-23.80%	-23.68%	-21.70%	0.91	7.44	90.80%	-102.10%	-87.84%
GRFS	GRIFOLS SA	$4.93B	7.20%	2.00%	6.45%	6.50%	2.30	2.51	38.00%	5.30%	15.18%
ACH	ACCENDRA HEALTH INC	$278.76M	N/A	-33.10%	-80.33%	-48.10%	-6.20	0.49	46.00%	-39.80%	-35.87%
BDSX	BIODESIX INC	$220.87M	-2,101.40%	-35.60%	-29.88%	-22.60%	9.36	2.82	82.10%	-33.30%	-24.92%
EOLS	EVOLUS INC	$460.32M	N/A	-19.40%	-15.27%	-12.20%	-8.67	2.04	66.10%	-14.40%	-7.72%
LXRX	LEXICON PHARMACEUTICALS INC	$1.03B	-18.60%	-11.80%	-6.95%	-12.50%	0.33	18.80	99.50%	-37.50%	-25.84%
CHE	CHEMED CORP	$6.38B	25.30%	16.20%	28.89%	60.50%	0.81	0.85	32.40%	10.20%	13.81%
RMD	RESMED INC	$31.68B	24.40%	18.00%	25.19%	59.10%	0.35	3.01	61.60%	27.40%	33.82%
SEPN	SEPTERNA INC	$1.51B	-9.40%	-6.60%	-7.26%	-10.80%	0.51	4.71	100.00%	-49.90%	-49.40%
VRTX	VERTEX PHARMACEUTICALS INC	$134.41B	23.90%	17.20%	22.90%	31.70%	0.37	3.02	86.20%	35.50%	42.36%
ANAB	ANAPTYSBIO INC	$1.81B	N/A	-7.80%	-9.25%	-5.80%	24.86	7.58	100.00%	-11.50%	-11.46%
TMO	THERMO FISHER SCIENTIFIC INC	$192.35B	13.20%	6.40%	8.96%	14.90%	1.18	1.53	40.80%	15.20%	19.56%
OMER	OMEROS CORP	$748.36M	-54.40%	34.50%	39.48%	16.70%	-5.52	3.03	94.10%	871.00%	904.87%
DHR	DANAHER CORP	$137.04B	7.10%	4.50%	6.06%	16.20%	0.58	1.87	58.90%	14.90%	18.60%
HCWB	HCW BIOLOGICS INC	$5.19M	-1,138.00%	-68.20%	-17.38%	-16.20%	3.75	0.09	100.00%	-277.00%	-19.61%
ANGO	ANGIODYNAMICS INC	$536.32M	-17.60%	-11.70%	-16.52%	-36.80%	0.50	2.35	54.30%	-10.00%	-10.25%
MTD	METTLER TOLEDO INTERNATIONAL INC	$26.18B	-610.30%	24.50%	43.95%	31.60%	-88.60	1.20	59.20%	21.40%	27.52%
JNJ	JOHNSON & JOHNSON	$624.26B	26.30%	10.70%	18.14%	34.70%	1.47	1.03	67.80%	21.80%	26.96%
ENTA	ENANTA PHARMACEUTICALS INC	$421.93M	-64.00%	-20.20%	-19.19%	-18.40%	1.70	3.84	100.00%	-89.60%	-74.39%
UNH	UNITEDHEALTH GROUP INC	$379.60B	12.60%	3.90%	8.94%	15.00%	2.12	0.80	18.80%	2.70%	3.95%
SPRO	SPERO THERAPEUTICS INC	$126.80M	35.60%	25.00%	28.95%	165.70%	0.12	10.50	100.00%	24.90%	25.33%
RGEN	REPLIGEN CORP	$7.98B	2.50%	1.80%	2.78%	5.90%	0.39	9.20	52.90%	6.70%	10.23%
HUM	HUMANA INC	$47.17B	6.20%	2.20%	6.02%	6.40%	1.97	1.77	14.00%	0.80%	1.48%
SGHT	SIGHT SCIENCES INC	$298.17M	-59.10%	-32.20%	-35.09%	-64.20%	1.04	5.86	86.20%	-46.80%	-40.38%
RVTY	REVVITY INC	$12.60B	3.30%	2.00%	3.35%	8.10%	0.67	1.72	54.30%	8.30%	12.43%
LAB	STANDARD BIOTOOLS INC	$346.26M	17.30%	13.60%	6.78%	11.70%	0.14	12.36	49.60%	90.70%	46.93%
NPCE	NEUROPACE INC	$590.84M	-120.70%	-20.60%	-17.82%	-10.70%	5.84	5.38	78.30%	-21.70%	-14.81%
ARGX	ARGENX SE	$56.73B	20.20%	17.40%	17.42%	34.00%	0.19	5.23	N/A	N/A	N/A
BFLY	BUTTERFLY NETWORK INC	$2.15B	-36.80%	-25.60%	-32.80%	-69.60%	0.50	4.03	49.20%	-73.60%	-72.15%
TVTX	TRAVERE THERAPEUTICS INC	$5.35B	-26.80%	-3.80%	-2.42%	-1.90%	4.62	3.13	98.60%	-4.00%	-1.94%
RLYB	RALLYBIO CORP	$83.29M	-14.40%	-13.30%	-15.53%	-30.10%	0.08	12.92	100.00%	-911.10%	-911.07%
OFIX	ORTHOFIX MEDICAL INC	$467.68M	-13.40%	-7.00%	-5.63%	-7.70%	1.04	2.87	70.70%	-7.30%	-4.95%
SLN	SILENCE THERAPEUTICS PLC	$499.24M	N/A	-53.70%	-71.69%	-94.10%	-1.33	9.83	79.50%	-8,943.90%	-8,942.55%
SIBN	SI-BONE INC	$784.10M	-9.60%	-7.10%	-6.39%	-6.50%	0.36	9.99	79.60%	-8.10%	-6.86%
NAGE	NIAGEN BIOSCIENCE INC	$278.76M	25.40%	18.20%	21.52%	118.30%	0.39	4.61	64.30%	14.30%	15.10%
HTFL	HEARTFLOW INC	$2.34B	N/A	-36.40%	-33.27%	-44.50%	0.20	5.57	78.10%	-58.40%	-53.18%
SYK	STRYKER CORP	$124.49B	15.10%	7.10%	13.40%	19.50%	1.01	2.11	63.80%	13.20%	21.19%
SLS	SELLAS LIFE SCIENCES GROUP INC	$2.59B	-47.10%	-42.60%	-27.35%	4,971.60%	0.06	17.22	N/A	N/A	N/A
NRC	NRC HEALTH	$507.08M	57.30%	6.60%	20.42%	18.40%	8.97	0.52	61.80%	6.50%	14.15%
PTN	PALATIN TECHNOLOGIES INC	$19.59M	-141.40%	-58.10%	-58.39%	260.00%	0.25	5.04	100.00%	-48.50%	-48.45%
AMWL	AMERICAN WELL CORP	$139.92M	-35.10%	-25.10%	-36.25%	-2,146.30%	0.38	3.09	52.90%	-37.00%	-36.99%
JANX	JANUX THERAPEUTICS INC	$939.77M	-11.80%	-11.20%	-11.81%	-11.90%	0.09	17.01	100.00%	-833.60%	-833.60%
INDP	INDAPTUS THERAPEUTICS INC	$322.74M	-1,028.80%	-299.70%	-1,511.20%	929.90%	0.75	2.34	N/A	N/A	N/A
AORT	ARTIVION INC	$1.20B	2.70%	1.30%	5.28%	7.30%	0.96	3.86	64.60%	2.50%	9.09%
UTMD	UTAH MEDICAL PRODUCTS INC	$228.64M	9.10%	8.90%	11.11%	68.10%	0.03	28.64	57.90%	28.90%	35.79%
ADAG	ADAGENE INC	$186.23M	-41.00%	-21.00%	-32.86%	113.30%	0.75	3.07	100.00%	-229.60%	-227.41%
HRMY	HARMONY BIOSCIENCES HOLDINGS INC	$2.14B	17.20%	12.00%	20.07%	48.50%	0.40	3.58	76.50%	16.20%	23.54%
PIII	P3 HEALTH PARTNERS INC	$74.55M	N/A	-18.40%	-49.25%	88.80%	-5.57	0.33	-2.20%	-8.60%	-4.97%
AMPH	AMPHASTAR PHARMACEUTICALS INC	$864.66M	10.20%	4.80%	8.67%	9.40%	1.13	3.85	47.30%	11.00%	17.84%
XRAY	DENTSPLY SIRONA INC	$2.47B	-41.20%	-11.20%	-11.93%	-11.60%	2.97	1.53	48.90%	-17.10%	-13.04%
PBH	PRESTIGE CONSUMER HEALTHCARE INC	$2.31B	10.30%	5.50%	8.89%	20.80%	0.85	3.57	54.70%	17.50%	27.54%
ICLR	ICON PLC	$13.09B	4.70%	2.70%	5.21%	16.50%	0.76	1.14	25.30%	5.40%	8.34%
STVN	STEVANATO GROUP SPA	$5.84B	9.70%	5.70%	10.63%	9.70%	0.69	1.63	29.00%	11.70%	17.87%
GEHC	GE HEALTHCARE TECHNOLOGIES INC	$29.50B	18.70%	5.20%	10.28%	16.00%	2.46	1.22	39.10%	9.10%	14.01%
ADPT	ADAPTIVE BIOTECHNOLOGIES CORP	$3.44B	-24.30%	-9.90%	-9.05%	-8.60%	1.30	3.35	75.30%	-16.80%	-12.84%
FMS	FRESENIUS MEDICAL CARE AG	$12.75B	7.20%	3.00%	6.59%	7.60%	1.30	1.21	26.00%	4.90%	8.42%
ELVN	ENLIVEN THERAPEUTICS INC	$3.05B	-21.00%	-20.40%	-21.79%	-27.70%	0.03	40.32	N/A	N/A	N/A
SGRY	SURGERY PARTNERS INC	$2.22B	-4.40%	-0.90%	2.95%	3.70%	2.93	1.86	22.80%	-2.30%	6.59%
GERN	GERON CORP	$923.79M	-28.00%	-12.10%	-7.75%	-5.50%	1.33	6.78	97.30%	-34.30%	-18.21%
KMDA	KAMADA LTD	$432.07M	7.70%	5.40%	7.15%	15.60%	0.48	3.33	41.20%	11.20%	12.72%
MXCT	MAXCYTE INC	$136.04M	-22.00%	-18.80%	-21.23%	-20.10%	0.16	12.04	80.50%	-121.20%	-121.16%
BDX	BECTON DICKINSON & CO	$42.86B	4.50%	2.10%	4.68%	7.10%	1.11	0.94	46.80%	5.30%	9.27%
TXG	10X GENOMICS INC	$5.08B	-2.90%	-2.20%	-2.13%	-4.10%	0.25	5.90	69.60%	-3.50%	-3.01%
PRPO	PRECIPIO INC	$45.15M	-6.70%	-4.50%	-5.06%	-13.10%	0.47	1.56	43.70%	-3.60%	-3.33%
ESTA	ESTABLISHMENT LABS HOLDINGS INC	$2.69B	-225.90%	-12.70%	-9.27%	-5.80%	22.75	2.96	70.10%	-19.10%	-10.82%
NIVF	NEWGENIVF GROUP LTD	$1.13M	77.20%	54.40%	34.58%	127.40%	0.25	3.12	20.20%	209.00%	222.07%
XLO	XILIO THERAPEUTICS INC	$56.48M	-117.20%	-21.40%	-25.97%	108.70%	1.25	3.59	100.00%	-58.50%	-58.52%
UTHR	UNITED THERAPEUTICS CORP	$23.23B	19.20%	17.20%	26.58%	30.40%	0.14	4.79	86.60%	40.60%	51.27%
MGNX	MACROGENICS INC	$290.48M	-147.80%	-28.40%	-47.34%	-26.80%	9.28	1.90	74.40%	-44.80%	-36.75%
UFPT	UFP TECHNOLOGIES INC	$2.10B	16.60%	10.50%	15.49%	23.90%	0.54	2.91	28.40%	11.30%	15.20%
GMRS	GMR SOLUTIONS INC	$776.69M	N/A	N/A	N/A	N/A	32.14	1.87	N/A	N/A	N/A
MYGN	MYRIAD GENETICS INC	$569.52M	-109.10%	-57.40%	-71.02%	-94.50%	1.00	2.40	70.00%	-48.20%	-46.56%
HSDT	SOLANA CO	$106.26M	-155.30%	-55.40%	-68.83%	-65.20%	0.01	9.90	94.20%	-1,427.10%	-1,420.59%
GDRX	GOODRX HOLDINGS INC	$1.04B	3.30%	1.40%	7.51%	10.70%	2.25	1.47	91.80%	2.60%	11.07%
ADMA	ADMA BIOLOGICS INC	$2.12B	39.00%	27.40%	36.10%	39.40%	0.70	6.95	61.30%	32.40%	41.89%
INSP	INSPIRE MEDICAL SYSTEMS INC	$1.42B	18.00%	15.30%	7.80%	9.40%	0.15	6.34	85.80%	14.30%	7.00%
IFRX	INFLARX NV	$152.54M	-94.90%	-70.70%	-114.27%	-126.30%	0.33	4.16	-24,646.30%	-146,303.90%	-146,091.95%
QGEN	QIAGEN NV	$8.10B	11.30%	6.60%	9.31%	15.40%	0.74	3.22	62.00%	19.20%	23.52%
INMD	INMODE LTD	$925.65M	13.30%	11.80%	15.18%	26.70%	0.14	8.80	77.80%	23.30%	27.28%
PRGO	PERRIGO CO PLC	$1.53B	-50.70%	-19.80%	-22.56%	-25.20%	2.20	2.72	34.20%	-43.50%	-37.71%
BNGO	BIONANO GENOMICS INC	$13.31M	-71.40%	-43.10%	-72.35%	-57.50%	0.73	1.84	47.00%	-109.90%	-109.70%
CBIO	CRESCENT BIOPHARMA INC	$467.62M	-100.90%	-88.20%	-85.98%	1,853.70%	0.08	13.78	100.00%	-1,494.60%	-1,466.29%
HYPR	HYPERFINE INC	$126.07M	-101.30%	-68.80%	-69.14%	-274.80%	0.76	5.52	51.20%	-226.90%	-226.34%
ITGR	INTEGER HOLDINGS CORP	$3.17B	8.20%	4.20%	6.14%	7.70%	1.01	3.76	26.40%	7.60%	10.61%
AVTX	AVALO THERAPEUTICS INC	$1.05B	-97.50%	-72.40%	-95.79%	-123.50%	0.46	7.66	100.00%	-143,627.10%	-143,340.68%
HCAT	HEALTH CATALYST INC	$169.22M	-99.80%	-50.10%	-81.15%	-99.80%	1.98	1.69	49.90%	-87.70%	-81.71%
RANI	RANI THERAPEUTICS HOLDINGS INC	$98.24M	-245.50%	-85.60%	-72.07%	-144.10%	0.58	3.40	100.00%	-929.10%	-864.78%
SOLV	SOLVENTUM CORP	$13.50B	30.70%	10.00%	18.57%	23.70%	1.84	1.07	53.70%	17.30%	24.16%
EVH	EVOLENT HEALTH INC	$645.64M	-83.70%	-24.60%	-31.01%	-44.80%	3.74	1.32	20.20%	-28.30%	-24.59%
MRNA	MODERNA INC	$32.46B	-36.70%	-26.60%	-34.51%	-33.60%	0.55	2.41	22.10%	-143.60%	-141.03%
TGTX	TG THERAPEUTICS INC	$8.49B	87.40%	42.80%	11.17%	13.50%	1.62	5.81	83.10%	66.00%	21.41%
ZYME	ZYMEWORKS INC	$1.85B	-37.80%	-25.20%	-23.03%	-31.60%	1.92	10.82	100.00%	-126.30%	-125.40%
AZTA	AZENTA INC	$1.18B	-10.70%	-8.80%	-13.25%	-28.40%	0.23	2.83	43.80%	-29.90%	-36.60%
ZTS	ZOETIS INC	$31.62B	62.40%	17.50%	27.01%	23.40%	3.69	3.15	71.80%	27.80%	37.21%
PYPD	POLYPID LTD	$101.58M	-366.30%	-143.80%	-229.81%	-391.20%	1.03	1.97	N/A	N/A	N/A
ARDX	ARDELYX INC	$1.32B	-38.10%	-11.90%	-9.22%	-6.60%	2.40	3.49	92.50%	-13.60%	-8.52%
TNDM	TANDEM DIABETES CARE INC	$1.06B	-68.30%	-10.00%	-9.92%	-8.10%	7.71	3.58	54.90%	-9.20%	-8.74%
NVS	NOVARTIS AG	$296.69B	31.70%	12.30%	19.53%	34.00%	2.07	0.85	75.40%	23.90%	30.08%
NRXS	NEURAXIS INC	$88.67M	-205.90%	-115.30%	-121.14%	604.80%	0.52	2.89	85.00%	-188.60%	-167.82%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	607	-0.35%	+1.25%	+17.06%	+23.30%	18.36x	5.58x	-117.23%	-12.44%	-9.70%	+53.25%	Strong Buy
Diagnostics & Research	52	-0.02%	+3.31%	+13.74%	+24.32%	12.22x	3.90x	-7.05%	+5.99%	+11.73%	+5.79%	Strong Buy
Drug Manufacturers - General	20	-1.78%	-1.15%	+6.00%	+41.69%	41.49x	7.69x	+34.41%	+12.47%	+22.05%	+5.17%	Buy
Drug Manufacturers - Specialty & Generic	76	-0.55%	+0.67%	+5.56%	-33.67%	-5.96x	1.59x	+7.48%	+4.58%	+50.37%	+33.52%	Strong Buy
Healthcare Plans	10	-1.69%	+1.38%	+4.28%	+24.98%	29.47x	2.54x	+8.80%	+2.75%	+6.81%	-4.37%	Buy
Health Information Services	53	+0.95%	+5.82%	+18.00%	-47.94%	13.03x	3.44x	-8.71%	-0.43%	-0.74%	+17.15%	Buy
Medical Care Facilities	49	-0.40%	+5.21%	+14.56%	-22.16%	16.94x	5.47x	-49.37%	+6.58%	+14.89%	+11.00%	Buy
Medical Devices	135	+0.32%	+2.05%	+7.00%	-99.44%	20.88x	3.11x	+6.02%	+5.31%	+8.92%	+25.36%	Strong Buy
Medical Distribution	10	-0.08%	+4.19%	+6.35%	+10.62%	25.05x	156.87x	-97.12%	+3.72%	+24.95%	+17.15%	Buy
Medical Instruments & Supplies	54	+0.29%	+3.84%	+8.63%	-1.99%	45.23x	3.44x	+5.72%	+6.68%	+10.17%	+19.56%	Strong Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Jul 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #1 top healthcare stock out of 1066 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: B, Financials: B, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 44, which is 18 points higher than the healthcare sector average of 26. It passed 14 out of 33 due diligence checks and has strong fundamentals. Bioventus has seen its stock return 72.73% over the past year, overperforming other healthcare stocks by 168 percentage points.

Bioventus has an average 1 year price target of $15.00, an upside of 27.33% from Bioventus's current stock price of $11.78.

Bioventus stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Bioventus, 33.33% have issued a Strong Buy rating, 66.67% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Immucell (NASDAQ:ICCC)

Immucell (NASDAQ:ICCC) is the #2 top healthcare stock out of 1066 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Immucell (NASDAQ:ICCC) is: Value: B, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: B.

Immucell (NASDAQ:ICCC) has a Due Diligence Score of 19, which is -7 points lower than the healthcare sector average of 26. Although this number is below the industry average, our proven quant model rates ICCC as a "A".It passed 6 out of 33 due diligence checks and has weak fundamentals. Immucell has seen its stock return 53.94% over the past year, overperforming other healthcare stocks by 149 percentage points.

3. Electromed (NYSEMKT:ELMD)

Electromed (NYSEMKT:ELMD) is the #3 top healthcare stock out of 1066 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Electromed (NYSEMKT:ELMD) is: Value: C, Growth: C, Momentum: B, Sentiment: A, Safety: B, Financials: A, and AI: C.

Electromed (NYSEMKT:ELMD) has a Due Diligence Score of 44, which is 18 points higher than the healthcare sector average of 26. It passed 15 out of 33 due diligence checks and has strong fundamentals. Electromed has seen its stock return 130.17% over the past year, overperforming other healthcare stocks by 225 percentage points.

Electromed has an average 1 year price target of $38.00, a downside of -17.94% from Electromed's current stock price of $46.31.

Electromed stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Electromed, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 74 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 33.28%, which is 31 percentage points higher than the healthcare sector average of 2.65%.

Dominari Holdings's dividend payout ratio of -19.1% indicates that its high dividend yield might not be sustainable for the long-term.

2. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 16%, which is 13 percentage points higher than the healthcare sector average of 2.65%.

Siga Technologies's dividend payout ratio of 206.9% indicates that its high dividend yield might not be sustainable for the long-term.

3. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) has an annual dividend yield of 14.02%, which is 11 percentage points higher than the healthcare sector average of 2.65%.

Embecta's dividend payout ratio of 31.2% indicates that its high dividend yield is sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.32% in the last day, and up 2.16% over the last week. Adapthealth was the among the top losers in the healthcare sector, dropping -4.55% yesterday.

AdaptHealth shares are trading lower after Baird lowered its price target on the stock from $18 to $15.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 43, which is 30 points higher than the healthcare sector average of 13. It passed 3 out of 7 valuation due diligence checks.

Embecta's stock has dropped -67.3% in the past year. It has overperformed other stocks in the healthcare sector by 27 percentage points.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 86, which is 73 points higher than the healthcare sector average of 13. It passed 6 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 514.31% in the past year. It has overperformed other stocks in the healthcare sector by 609 percentage points.

3. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Inmode has a valuation score of 57, which is 44 points higher than the healthcare sector average of 13. It passed 4 out of 7 valuation due diligence checks.

Inmode's stock has dropped -3.31% in the past year. It has overperformed other stocks in the healthcare sector by 91 percentage points.

Are healthcare stocks a good buy now?

61.98% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 27.99% over the next year.

5.22% of healthcare stocks have a Zen Rating of A (Strong Buy), 13.31% of healthcare stocks are rated B (Buy), 48.38% are rated C (Hold), 26% are rated D (Sell), and 7.09% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 29.6x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Immucell (NASDAQ:ICCC)

3. Electromed (NYSEMKT:ELMD)

1. Dominari Holdings (NASDAQ:DOMH)

2. Siga Technologies (NASDAQ:SIGA)

3. Embecta (NASDAQ:EMBC)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Inmode (NASDAQ:INMD)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Immucell (NASDAQ:ICCC)

3. Electromed (NYSEMKT:ELMD)

1. Dominari Holdings (NASDAQ:DOMH)

2. Siga Technologies (NASDAQ:SIGA)

3. Embecta (NASDAQ:EMBC)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Inmode (NASDAQ:INMD)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.